Literature DB >> 18235520

Peeking into the black box: new biomarkers for acute kidney injury.

J M Thurman1, C R Parikh.   

Abstract

The development of effective therapies for acute kidney injury (AKI) has been hindered by delayed diagnosis in the clinical setting, varying definitions of AKI, and limited prognostic information. In a study by Portilla et al., elevations in liver fatty acid-binding protein (L-FABP) were found to predict AKI in children undergoing cardiac surgery. New biomarkers offer the promise of earlier and more accurate diagnosis of AKI. Before they can be deemed clinically useful, however, they must undergo rigorous validation in multiple cohorts.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18235520     DOI： 10.1038/sj.ki.5002739

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  11 in total

1.  Modified Hydrogels to Enhance Cellular Therapy for AKI: A Translational Challenge.

Authors:  Anna Gooch; Christof Westenfelder
Journal:  J Am Soc Nephrol       Date:  2016-02-11       Impact factor: 10.121

Review 2.  Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.

Authors:  Suree Lekawanvijit; Henry Krum
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

3.  Heart-kidney biomarkers in patients undergoing cardiac stress testing.

Authors:  Mikko Haapio; Andrew A House; Massimo de Cal; Dinna N Cruz; Paolo Lentini; Davide Giavarina; Antonio Fortunato; Luigi Menghetti; Matteo Salgarello; Andrea Lupi; Giuliano Soffiati; Alessandro Fontanelli; Pierluigi Zanco; Claudio Ronco
Journal:  Int J Nephrol       Date:  2010-10-20

4.  Predictive performance of urine neutrophil gelatinase-associated lipocalin for dialysis requirement and death following cardiac surgery in neonates and infants.

Authors:  Mirela Bojan; Stéphanie Vicca; Vanessa Lopez-Lopez; Agnes Mogenet; Philippe Pouard; Bruno Falissard; Didier Journois
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

Review 5.  Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury.

Authors:  Eisei Noiri; Kent Doi; Kousuke Negishi; Tamami Tanaka; Yoshifumi Hamasaki; Toshiro Fujita; Didier Portilla; Takeshi Sugaya
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-19

6.  Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study.

Authors:  Francesco Lapi; Laurent Azoulay; Hui Yin; Sharon J Nessim; Samy Suissa
Journal:  BMJ       Date:  2013-01-08

7.  Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers.

Authors:  Paolo Lentini; Massimo de Cal; Anna Clementi; Angela D'Angelo; Claudio Ronco
Journal:  Crit Care Res Pract       Date:  2012-02-14

8.  The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI.

Authors:  Norbert Lameire; Wim Van Biesen; Eric Hoste; Raymond Vanholder
Journal:  NDT Plus       Date:  2008-12

9.  Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study.

Authors:  Kent Doi; Masahiro Urata; Daisuke Katagiri; Mikako Inamori; Seiichiro Murata; Motoyuki Hisagi; Minoru Ono; Takehiro Matsubara; Takeshi Ishii; Naoki Yahagi; Masaomi Nangaku; Eisei Noiri
Journal:  Crit Care       Date:  2013-11-12       Impact factor: 9.097

Review 10.  The potential use of biomarkers in predicting contrast-induced acute kidney injury.

Authors:  Michele Andreucci; Teresa Faga; Eleonora Riccio; Massimo Sabbatini; Antonio Pisani; Ashour Michael
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.